Stay updated on LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.

Latest updates to the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded the NIH grant/contract identifier (2019 ( U.S. NIH Grant/Contract )) to the list of Other Study ID Numbers. Updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page shows a new revision label: v3.6.5 instead of v3.6.4, indicating a minor update or patch. The overall study details and navigation remain unchanged.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a maintenance update to the page’s version label. The change affects only the metadata and does not modify study content or user-facing information.SummaryDifference0.0%

- Check72 days agoChange DetectedFooter now shows Revision: v3.6.3, replacing the previous v3.6.2. This represents a minor update to the study page's documentation/versioning, with no changes to the study content or user-facing information.SummaryDifference0.0%

- Check79 days agoChange DetectedActual enrollment updated to 379 as of 2026-06-22, replacing the prior estimated 500 from 2025-06-03. The record revision is noted as Revision: v3.6.2.SummaryDifference0.2%

- Check93 days agoChange DetectedAdded recruitment status and new user guidance sections (No longer looking for participants; How to Read a Study Record; Common Questions; How to Join a Study). Updated page revision to v3.6.0 and adjusted the Intervention/Treatment labeling.SummaryDifference0.2%

Stay in the know with updates to LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.